Lecturer in Law
Bruce N. Kuhlik is Executive Vice President and General Counsel of Merck & Co., Inc. Bruce is responsible for the Office of General Counsel and the Global Communications, Public Policy, Corporate Responsibility and Security functions. He is also a member of Merck's Executive Committee, the senior management group that oversees the Company's strategic direction. Bruce joined Merck as Vice President and Associate General Counsel in 2005, with responsibility for product liability and other litigation and regulatory and commercial law. He was promoted to General Counsel in 2007.
Before coming to Merck, Bruce was Senior Vice President and General Counsel of the Pharmaceutical Research and Manufacturers of America (PhRMA), the principal trade association representing the innovative pharmaceutical industry in the United States, from 2002-2005. Bruce was a partner in the Washington, DC office of the law firm of Covington & Burling from 1990-2002 and an associate in the firm from 1982-1984 and 1986-1990. Among other responsibilities, Bruce served as the coordinator of the firm’s food and drug and healthcare practice groups. He advised pharmaceutical companies on all aspects of FDA regulatory requirements as well as Medicare and Medicaid law; litigated numerous cases under the Hatch-Waxman Act, the Freedom of Information Act and the FDA Modernization Act; and worked on many important pieces of legislation affecting the industry. He is co-author of a book on drug exports and author of several articles on issues facing the pharmaceutical industry.
From 1984-1986, Bruce served as Assistant to the Solicitor General in the U.S. Department of Justice, where he briefed and argued cases before the Supreme Court. From 1981-1982, he was a law clerk to Judge Levin Campbell of the U.S. Court of Appeals for the First Circuit.
Bruce received his A.B., summa cum laude, from Harvard College in 1978 and his J.D., magna cum laude, from Harvard Law School in 1981, where he was an editor of the Law Review. He is a member of the bar of the District of Columbia and holds in-house licenses in New Jersey and Pennsylvania. He is a member of the American Law Institute, the board of the Pro Bono Partnership, the Association of General Counsel, the PhRMA Law Section Executive Committee and the Leadership Council on Legal Diversity.